NCT07053202 2025-07-08TACE With Immune Agents for Angiogenesis in Hepatocellular CarcinomaThe First Hospital of Hebei Medical UniversityPhase NA Completed140 enrolled
NCT05233358 2022-02-10HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or FailureThe Central Hospital of Lishui CityPhase NA Unknown176 enrolled